Celera and Medical Therapies (NASDAQ:CRA)
Source: http://feedproxy.google.com/~r/FavStocks/~3/UXJYoQx7anE/Posted on Friday, October 30th, 2009 | In Biotech, Investing Lessons, Stocks to Watch
On a late Thursday evening, Celera Corporation (NASDAQ:CRA) and Medical Therapies Limited have announced that they have entered an exclusive license agreement for the use of Medical Therapies’ midkine patent portfolio for the development of novel lung cancer diagnostics. According to the license agreement, Celera will be able to use the Medical Therapies’ midkine patents for the commercialization and development of diagnostic products to address a range of lung cancer related applications which includes risk assessment, differentiation, prognosis, early detection system, disease progression, response to treatment and monitoring of reoccurrence. Celera Corporation and Medical Therapies Limited both are happy about the intellectual property agreement.
Celera Corporation is one of the upcoming healthcare companies that handles personalized disease management products and services and looks after three main segments which are clinical laboratory testing services, product business and activities under corporate management. The lab service of Celera Corporation is provided by BHL also known as Berkeley HeartLab, Inc which conducts clinical lab test and disease management services. On the other hand, Medical Therapies Limited is a biopharmaceutical company that owns the largest and the most comprehensive intellectual property portfolio around midkine globally which is a novel therapeutic and diagnostic target.
Celera and Medical Therapies stated that the license agreements also include upfront payments and milestone payments as well including the royalties on net product sales for the life of relevant patents. However, the companies did not mention any other financial details publicly. Executives of Medical Therapies said that they are happy that they have licensed their technology to Celera Corporation who has succeeded in the development of genomics and in particular diagnostic products. Celera Corporation is currently using a novel mass spectrometry-based approach to identify potential circulating protein biomarkers for non-small cell lung cancer and believe that midkine could play an important role in their research.
Last 5 posts by Jay Garcilazo
- Dyax approaching its PDUFA Date (DYAX) - November 24th, 2009
- FDA Decision scheduled for Santarus (SNTS) - November 23rd, 2009
- FDA Decision scheduled for Santarus (SNTS) - November 23rd, 2009
- CytRx Technical Breakout on Pending News (NASDAQ:CYTR) - November 23rd, 2009
- CytRx Technical Breakout on Pending News (NASDAQ:CYTR) - November 23rd, 2009
Berkeley HeartLab Inc, Biopharmaceutical, Biotech, Celera Corporation;, clinical laboratory testing services;, corporate management;, Diagnostic Products, disease management services, FavStocks, genomics, healthcare, Investing Lessons, Lung Cancer, Medical Therapies Limited, personalized disease, personalized disease management products, small cell lung cancer, Stocks to Watch
 About Jay Garcilazo (http://favstocks.com)
I grew up in Boca Raton, Florida. After graduating high school I enrolled at Florida State University where I studied Journalism and Political Science. It was around this time that I got a job in the healthcare industry, a job that would give me a lot of experience as I worked and moved up over the next four and a half years. This along with working for a hedge fund manager for years, were the greatest learning experiences of my life so far. I have also been fortunate enough to have lived all over the country in, Austin, Texas, Queens, New York, Great Falls, Montana, Cleveland, Ohio, Chattanooga, Tennessee, Atlanta, Georgia, and all over the state of Florida. As well as living in many places I have traveled all over, been to all of the states except California (Had a layover at LAX once but I don’t think that counts), Oregon, and Hawaii. Traveled most of the Caribbean, I have also been to many destinations in Canada, and Mexico. I even did a stint through Europe. As well as traveling and living all over I have also worked in a great many industries. I have been employed in finance, healthcare, title, mortgage, travel, video game development, hospitality, and news industries. Besides working for an investment company I have also done quite a bit of investing on my own, and through trial and error, learning from mistakes, and watching the news very closely I have made some decent money for myself. |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.